Crescent Capital BDC (NASDAQ:CCAP) Price Target Lowered to $16.00 at Wells Fargo & Company

Crescent Capital BDC (NASDAQ:CCAP) had its target price trimmed by Wells Fargo & Company from $18.00 to $16.00 in a research note released on Monday morning,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

Separately, Keefe, Bruyette & Woods cut their price target on shares of Crescent Capital BDC from $20.00 to $18.50 and set an “outperform” rating for the company in a research note on Tuesday, April 8th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $18.50.

Crescent Capital BDC Price Performance

NASDAQ:CCAP opened at $15.97 on Monday. Crescent Capital BDC has a 52-week low of $13.54 and a 52-week high of $20.19. The stock has a fifty day moving average of $16.61 and a 200 day moving average of $18.28. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32. The firm has a market capitalization of $591.88 million, a price-to-earnings ratio of 8.03 and a beta of 0.56.

Crescent Capital BDC (NASDAQ:CCAP) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The business had revenue of $46.40 million for the quarter, compared to the consensus estimate of $47.27 million. On average, research analysts expect that Crescent Capital BDC will post 2.09 EPS for the current fiscal year.

Crescent Capital BDC Announces Dividend

The company also recently disclosed a dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be issued a dividend of $0.05 per share. The ex-dividend date of this dividend is Friday, May 30th. Crescent Capital BDC’s dividend payout ratio is 84.42%.

Institutional Trading of Crescent Capital BDC

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Ieq Capital LLC lifted its holdings in shares of Crescent Capital BDC by 2.6% in the 4th quarter. Ieq Capital LLC now owns 22,725 shares of the company’s stock worth $437,000 after acquiring an additional 584 shares during the last quarter. Confluence Investment Management LLC lifted its stake in Crescent Capital BDC by 0.9% in the fourth quarter. Confluence Investment Management LLC now owns 73,839 shares of the company’s stock worth $1,419,000 after purchasing an additional 633 shares during the last quarter. Denali Advisors LLC boosted its position in Crescent Capital BDC by 0.5% during the fourth quarter. Denali Advisors LLC now owns 183,783 shares of the company’s stock valued at $3,532,000 after buying an additional 855 shares during the period. Van ECK Associates Corp grew its stake in shares of Crescent Capital BDC by 2.3% during the fourth quarter. Van ECK Associates Corp now owns 45,562 shares of the company’s stock valued at $876,000 after buying an additional 1,006 shares during the last quarter. Finally, Wells Fargo & Company MN increased its holdings in shares of Crescent Capital BDC by 0.5% in the fourth quarter. Wells Fargo & Company MN now owns 253,182 shares of the company’s stock worth $4,866,000 after buying an additional 1,210 shares during the period. Hedge funds and other institutional investors own 49.46% of the company’s stock.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.